AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32379629 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) applied to the sternocleidomastoid, upper trapezius, and levator scapulae muscles
Number of subjects: 30
Study 32379629 — intervention group
Group type: COMPARATOR
Intervention: Sham taping (ST)
Number of subjects: 30
Study 35015847 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17160
Study 35015847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17160
Study 34290337 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention (6 weeks)
Number of subjects: 60
Study 34290337 — intervention group
Group type: COMPARATOR
Intervention: Massage intervention (6 weeks)
Number of subjects: 60
Study 34290337 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga post-massage exposure (6 weeks)
Number of subjects: 60
Study 34290337 — intervention group
Group type: COMPARATOR
Intervention: Massage post-yoga exposure (6 weeks)
Number of subjects: 60
Study 32259414 — intervention group
Group type: EXPERIMENTAL
Intervention: CT‐CP/OPF (Opalescence PF‐10%)
Number of subjects: 10
Study 32259414 — intervention group
Group type: EXPERIMENTAL
Intervention: PT‐HP/OGO (Opalescence GO‐10%)
Number of subjects: 10
Study 32259414 — intervention group
Group type: EXPERIMENTAL
Intervention: CT‐HP/WTC (White Class‐10%)
Number of subjects: 10
Study 35020101 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nalbuphine 2 mg/ml (Group A)
Number of subjects: 189
Study 35020101 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical nalbuphine 1 mg/ml (Group B)
Number of subjects: 189
Study 35020101 — intervention group
Group type: COMPARATOR
Intervention: Topical artificial tears (Group C)
Number of subjects: 189
Study 35020101 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 189
Study 35383732 — intervention group
Group type: EXPERIMENTAL
Intervention: SYSTANE iLux
Number of subjects: 236
Study 35383732 — intervention group
Group type: COMPARATOR
Intervention: LipiFlow
Number of subjects: 236
Study 32991652 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic Calcium Phosphate (BCP)
Number of subjects: 51
Study 32991652 — intervention group
Group type: COMPARATOR
Intervention: Deproteinized Bovine Bone Mineral (DBBM)
Number of subjects: 51
Study 34933333 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine 75 mg/m2 on days 1 through 7 with durvalumab 1500 mg on day 1 every 4 weeks (Arm A)
Number of subjects: 129
Study 34933333 — intervention group
Group type: COMPARATOR
Intervention: Azacitidine 75 mg/m2 on days 1 through 7 without durvalumab (Arm B)
Number of subjects: 129
Study 33729467 — intervention group
Group type: EXPERIMENTAL
Intervention: nCRT (neoadjuvant chemoradiotherapy) followed by minimally invasive esophagectomy (MIE)
Number of subjects: 264
Study 33729467 — intervention group
Group type: COMPARATOR
Intervention: nCT (neoadjuvant chemotherapy) followed by minimally invasive esophagectomy (MIE)
Number of subjects: 264
Study 32599257 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared Decision Support Intervention (PtDAs including pamphlet and video)
Number of subjects: 900
Study 32599257 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 900
Study 33515267 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nicotinic e-cigarettes with 4 mg nicotine lozenge (ENL)
Number of subjects: 41
Study 33515267 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg nicotine lozenge (NL)
Number of subjects: 41
Study 33515267 — intervention group
Group type: COMPARATOR
Intervention: Tobacco cigarettes (CIG)
Number of subjects: 41
Study 33515267 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nicotinic e-cigarettes with placebo lozenges (EPL)
Number of subjects: 41
Study 33450074 — intervention group
Group type: EXPERIMENTAL
Intervention: Well-Being Therapy (WBT)
Number of subjects: 0
Study 33450074 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 0
Study 32769965 — intervention group
Group type: EXPERIMENTAL
Intervention: Inotuzumab ozogamicin (InO)
Number of subjects: 265
Study 32769965 — intervention group
Group type: COMPARATOR
Intervention: Standard of care chemotherapy (SC)
Number of subjects: 265
Study 34981580 — intervention group
Group type: EXPERIMENTAL
Intervention: Red Light (RL) therapy
Number of subjects: 28
Study 34981580 — intervention group
Group type: COMPARATOR
Intervention: Blue Light (BL) therapy
Number of subjects: 28
Study 34476756 — intervention group
Group type: EXPERIMENTAL
Intervention: Kerà K2 (medical device containing 2,4,6‐octatrienoic acid and urea)
Number of subjects: 70
Study 34476756 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 35121105 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin Gammanorm® via pump
Number of subjects: 30
Study 35121105 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous immunoglobulin Gammanorm® via rapid push
Number of subjects: 30
Study 35121105 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous immunoglobulin Gammanorm® via pump and rapid push
Number of subjects: 30
Study 32143084 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Body Positive Pressure Treadmill (LBPPT) at 100% body weight
Number of subjects: 12
Study 32143084 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Body Positive Pressure Treadmill (LBPPT) at 90% body weight
Number of subjects: 12
Study 32143084 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Body Positive Pressure Treadmill (LBPPT) at 80% body weight
Number of subjects: 12
Study 32143084 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Body Positive Pressure Treadmill (LBPPT) at 70% body weight
Number of subjects: 12
Study 32143084 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Body Positive Pressure Treadmill (LBPPT) at 60% body weight
Number of subjects: 12
Study 32143084 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower Body Positive Pressure Treadmill (LBPPT) at varying %BW
Number of subjects: 12
Study 35491797 — intervention group
Group type: EXPERIMENTAL
Intervention: Short pulse width stimulation (30μs)
Number of subjects: 24
Study 35491797 — intervention group
Group type: COMPARATOR
Intervention: Conventional pulse width stimulation (60μs)
Number of subjects: 24
Study 33861548 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive haloperidol (up to 28 days)
Number of subjects: 1495
Study 33861548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1495
Study 85146433 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation during immobilization
Number of subjects: 15
Study 85146433 — intervention group
Group type: COMPARATOR
Intervention: Nonstimulation
Number of subjects: 15
Study 85146433 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation to the quadriceps
Number of subjects: 15
Study 35029142 — intervention group
Group type: EXPERIMENTAL
Intervention: Racial/ethnic minority mothers
Number of subjects: 343
Study 33773207 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1000 mg) with methotrexate (7.5 mg/week)
Number of subjects: 120
Study 33773207 — intervention group
Group type: COMPARATOR
Intervention: Placebo with methotrexate (7.5 mg/week)
Number of subjects: 120
Study 36006437 — intervention group
Group type: EXPERIMENTAL
Intervention: (chemo)radiotherapy with larynx V50Gy ≥ 53%
Number of subjects: 61
Study 36006437 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic or reactive gastrostomy tube placement
Number of subjects: 61
Study 33180541 — intervention group
Group type: EXPERIMENTAL
Intervention: Household-smoking ban
Number of subjects: 284
Study 33180541 — intervention group
Group type: COMPARATOR
Intervention: Continued smoking without a ban
Number of subjects: 284
Study 33171390 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based maintenance program
Number of subjects: 97
Study 33171390 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 97
Study 33389108 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + AE (aerobic exercise using active-play video games and traditional equipment)
Number of subjects: 33
Study 33389108 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU + AE (aerobic exercise)
Number of subjects: 33
Study 33389108 — intervention group
Group type: COMPARATOR
Intervention: TAU (Treatment-As-Usual)
Number of subjects: 33
Study 35090435 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Facet Joint Fusion (MFF)
Number of subjects: 77
Study 35090435 — intervention group
Group type: COMPARATOR
Intervention: Posterolateral Fusion (PLF)
Number of subjects: 77
Study 32022483 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate-formoterol (MF/F) 100/10 µg
Number of subjects: 181
Study 32022483 — intervention group
Group type: COMPARATOR
Intervention: Mometasone furoate (MF) 100 µg
Number of subjects: 181
Study 35384019 — intervention group
Group type: EXPERIMENTAL
Intervention: Small cribriform pattern
Number of subjects: 1887
Study 35384019 — intervention group
Group type: EXPERIMENTAL
Intervention: Large cribriform pattern
Number of subjects: 1887
Study 32387012 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACYW-TT
Number of subjects: 906
Study 32387012 — intervention group
Group type: COMPARATOR
Intervention: MPSV4
Number of subjects: 906
Study 35451099 — intervention group
Group type: EXPERIMENTAL
Intervention: THC cigarette
Number of subjects: 14
Study 35451099 — intervention group
Group type: COMPARATOR
Intervention: Placebo cigarette
Number of subjects: 14
Study 35583988 — intervention group
Group type: EXPERIMENTAL
Intervention: Group logotherapy (10 weekly 2-hour sessions)
Number of subjects: 63
Study 35583988 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 63
Study 33559240 — intervention group
Group type: EXPERIMENTAL
Intervention: Long pulsed Nd:YAG laser
Number of subjects: 20
Study 33559240 — intervention group
Group type: COMPARATOR
Intervention: Chemical peeling
Number of subjects: 20
Study 33167542 — intervention group
Group type: EXPERIMENTAL
Intervention: High-histamine diet for 4 weeks
Number of subjects: 21
Study 33167542 — intervention group
Group type: COMPARATOR
Intervention: Low-histamine diet for 4 weeks
Number of subjects: 21
Study 35244059 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 165
Study 35244059 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 165
Study 33888577 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 1445
Study 33888577 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1445
Study 33888577 — intervention group
Group type: COMPARATOR
Intervention: Tolvaptan and Placebo
Number of subjects: 1445
Study 33225801 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal management training (support condition)
Number of subjects: 90
Study 33225801 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 90
Study 33225801 — intervention group
Group type: EXPERIMENTAL
Intervention: Older adults
Number of subjects: 90
Study 32781476 — intervention group
Group type: EXPERIMENTAL
Intervention: Bihemispheric transcranial direct current stimulation
Number of subjects: 17
Study 32781476 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 17
Study 32777998 — intervention group
Group type: COMPARATOR
Intervention: L-theanine 400 mg
Number of subjects: 27
Study 32777998 — intervention group
Group type: COMPARATOR
Intervention: L-theanine 100 mg
Number of subjects: 27
Study 32777998 — intervention group
Group type: COMPARATOR
Intervention: L-theanine 200 mg
Number of subjects: 27
Study 32777998 — intervention group
Group type: COMPARATOR
Intervention: Placebo (distilled water)
Number of subjects: 27
Study 34816597 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop (HCL) insulin delivery 24/7
Number of subjects: 122
Study 34816597 — intervention group
Group type: COMPARATOR
Intervention: Evening and night (E/N) hybrid closed-loop insulin delivery
Number of subjects: 122
Study 34805194 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo injections (two per day on day 1 and 2 post-surgery) along with treatment as usual (patient-controlled morphine pump)
Number of subjects: 70
Study 34805194 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (patient-controlled morphine pump)
Number of subjects: 70
Study 34805194 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo injections
Number of subjects: 70
Study 36342884 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient NIV setup using an autotitrating NIV device and a set protocol, including home oximetry.
Number of subjects: 82
Study 36342884 — intervention group
Group type: COMPARATOR
Intervention: Inpatient NIV setup with standard fixed level NIV and titrated during an attended overnight respiratory study.
Number of subjects: 82
Study 36342884 — intervention group
Group type: EXPERIMENTAL
Intervention: Both outpatient and inpatient NIV setups.
Number of subjects: 82
Study 32056510 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% glucose mouth rinse
Number of subjects: 10
Study 32056510 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% NaCl mouth rinse
Number of subjects: 10
Study 32056510 — intervention group
Group type: COMPARATOR
Intervention: Water mouth rinse
Number of subjects: 10
Study 35618537 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced regional analgesic techniques
Number of subjects: 0
Study 35618537 — intervention group
Group type: COMPARATOR
Intervention: Basic analgesics (paracetamol, NSAIDs, cyclooxygenase-2 inhibitors, dexamethasone, local infiltration analgesia)
Number of subjects: 0
Study 33430935 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality Improvement Dashboards (QID) and Targeted Client Communication (TCC) via SMS
Number of subjects: 138
Study 33430935 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 138
Study 32938572 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire assessing knowledge, attitude, and practice regarding emergency management of TDI.
Number of subjects: 330
Study 32938572 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire assessing perceived knowledge level.
Number of subjects: 330
Study 32938572 — intervention group
Group type: EXPERIMENTAL
Intervention: Need for a training program expressed by all respondents.
Number of subjects: 330
Study 32248707 — intervention group
Group type: EXPERIMENTAL
Intervention: Polynucleotide (PN) filler injection
Number of subjects: 27
Study 32248707 — intervention group
Group type: COMPARATOR
Intervention: Non-crosslinked hyaluronic acid (HA) filler injection
Number of subjects: 27
Study 33975661 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone pâté
Number of subjects: 68
Study 33975661 — intervention group
Group type: COMPARATOR
Intervention: Bioactive glass
Number of subjects: 68
Study 32975529 — intervention group
Group type: EXPERIMENTAL
Intervention: Portal message promoting influenza vaccinations
Number of subjects: 19506
Study 32975529 — intervention group
Group type: COMPARATOR
Intervention: Usual care for portal users
Number of subjects: 19506
Study 32975529 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive voice response call
Number of subjects: 19506
Study 32975529 — intervention group
Group type: COMPARATOR
Intervention: Usual care for portal nonusers
Number of subjects: 19506
Study 36127727 — intervention group
Group type: EXPERIMENTAL
Intervention: Acipimox
Number of subjects: 120
Study 36127727 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 120
Study 32311655 — intervention group
Group type: EXPERIMENTAL
Intervention: m-dimensional randomized sketches approach for KCCA
Number of subjects: 0
Study 32311655 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 36477104 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound
Number of subjects: 44
Study 36477104 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraffin with vacuum massage
Number of subjects: 44
Study 36477104 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraffin alone
Number of subjects: 44
Study 36477104 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic ultrasound and vacuum massage
Number of subjects: 44
Study 36477104 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 44
Study 34264838 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioner (GP) characteristics and practice characteristics in New Zealand
Number of subjects: 6146
Study 34264838 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioner (GP) characteristics and practice characteristics in the Netherlands
Number of subjects: 6146
Study 32047015 — intervention group
Group type: EXPERIMENTAL
Intervention: Total laparoscopic pancreaticoduodenectomy (TLPD)
Number of subjects: 656
Study 32047015 — intervention group
Group type: COMPARATOR
Intervention: Open pancreaticoduodenectomy (OPD)
Number of subjects: 656
Study 35807110 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral QLBs-LSAL with 0.375% ropivacaine (20 mL each side)
Number of subjects: 94
Study 35807110 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral QLBs-LSAL
Number of subjects: 94
Study 35807110 — intervention group
Group type: COMPARATOR
Intervention: Bilateral TQLBs
Number of subjects: 94
Study 35240291 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol 200 mg once daily for 24 weeks
Number of subjects: 110
Study 35240291 — intervention group
Group type: COMPARATOR
Intervention: Placebo (cellulose capsules)
Number of subjects: 110
Study 33057887 — intervention group
Group type: EXPERIMENTAL
Intervention: St. John's wort oil
Number of subjects: 90
Study 33057887 — intervention group
Group type: EXPERIMENTAL
Intervention: Virgin olive oil
Number of subjects: 90
Study 33057887 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine gluconate plus benzydamine hydrochloride mouthwash
Number of subjects: 90
Study 35867532 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant hypnotherapy plus conventional therapy
Number of subjects: 41
Study 35867532 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy alone (control)
Number of subjects: 41
Study 33881456 — intervention group
Group type: EXPERIMENTAL
Intervention: end-HMPo2
Number of subjects: 305
Study 33881456 — intervention group
Group type: COMPARATOR
Intervention: SCS
Number of subjects: 305
Study 32799216 — intervention group
Group type: COMPARATOR
Intervention: C-arm-guided PKP
Number of subjects: 60
Study 32799216 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-arm DSA-guided PKP
Number of subjects: 60
Study 35279171 — intervention group
Group type: EXPERIMENTAL
Intervention: Anaemia screening and treatment (anaemia arm)
Number of subjects: 19254
Study 35279171 — intervention group
Group type: EXPERIMENTAL
Intervention: MSSA decolonisation (infection arm)
Number of subjects: 19254
Study 34792268 — intervention group
Group type: EXPERIMENTAL
Intervention: EBUS-TBNA
Number of subjects: 358
Study 34792268 — intervention group
Group type: COMPARATOR
Intervention: EUS-B-FNA
Number of subjects: 358
Study 34205403 — intervention group
Group type: EXPERIMENTAL
Intervention: Food education programme based on the stages of change model
Number of subjects: 74
Study 34205403 — intervention group
Group type: COMPARATOR
Intervention: Informative sessions on basic healthy eating (Control Group)
Number of subjects: 74
Study 33932802 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined EN and PN with omega‐3 PUFA
Number of subjects: 100
Study 33932802 — intervention group
Group type: COMPARATOR
Intervention: Combined EN and PN without omega‐3 PUFA (control group)
Number of subjects: 100
Study 32379066 — intervention group
Group type: EXPERIMENTAL
Intervention: RIRS
Number of subjects: 168
Study 32379066 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro PNL
Number of subjects: 168
Study 32379066 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultra-mini PNL
Number of subjects: 168
Study 32379066 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini PNL
Number of subjects: 168
Study 32379066 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard PNL
Number of subjects: 168
Study 34376084 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonphysical IPV items (6 items)
Number of subjects: 2412
Study 34376084 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex and identifying as lesbian, gay, or bisexual
Number of subjects: 2412
Study 34376084 — intervention group
Group type: COMPARATOR
Intervention: Measurement invariance assumptions and dichotomization of IPV
Number of subjects: 2412
Study 34003138 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational interventions through a mobile phone app and nurse-assisted online support sessions for 4 weeks
Number of subjects: 82
Study 34003138 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational interventions through a mobile phone app
Number of subjects: 82
Study 34003138 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 82
Study 32673128 — intervention group
Group type: EXPERIMENTAL
Intervention: Partitioned-survival analysis (PartSA)
Number of subjects: 700
Study 32673128 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-Markov multi-state model (MSM)
Number of subjects: 700
Study 32673128 — intervention group
Group type: EXPERIMENTAL
Intervention: PartSA
Number of subjects: 700
Study 32673128 — intervention group
Group type: EXPERIMENTAL
Intervention: MSM
Number of subjects: 700
Study 35556170 — intervention group
Group type: EXPERIMENTAL
Intervention: PF‐72 mixed with 0.75% ropivacaine
Number of subjects: 99
Study 35556170 — intervention group
Group type: COMPARATOR
Intervention: 0.75% ropivacaine
Number of subjects: 99
Study 35556170 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 99
Study 33087250 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose oral vitamin D3 (540,000 IU)
Number of subjects: 428
Study 33087250 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 428
Study 35084880 — intervention group
Group type: EXPERIMENTAL
Intervention: TAU plus Focused Coparenting Consultation (FCC) sessions
Number of subjects: 138
Study 35084880 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 138
Study 33916906 — intervention group
Group type: EXPERIMENTAL
Intervention: Primavera programme
Number of subjects: 287
Study 33916906 — intervention group
Group type: COMPARATOR
Intervention: Control prevention intervention
Number of subjects: 287
Study 33745547 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus plus rituximab
Number of subjects: 0